Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01992432 · ClinicalTrials.gov registry record

Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)

A clinical trial of Breast Cancer, sponsored by City of Hope Medical Center.

Active
Registry status
49
Enrollment target
2
Study locations

NCT01992432 is a study of Breast Cancer that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 49 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01992432, a study of Breast Cancer, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
49 participants
Enrollment target
2
Study locations

Study Summary

This study will use advanced MRI techniques to characterize the changes that occur to the structure and functionality of the brain in older breast cancer patients receiving adjuvant chemotherapy, and determine the relationship between the brain changes and severity of chemotherapy toxicity. Our results will be an early step towards identifying neuroimaging markers of aging, breast cancer and chemotherapy treatment, and will contribute to our understanding of the underlying pathophysiology of cognitive changes and chemotherapy toxicity in vulnerable, older adults with cancer. Furthermore, the work will lay the foundation for future, larger scale clinical studies of cognitive changes and chemotherapy toxicity in the aging cancer population.

Conditions Studied

Study Locations (2)

California

  • City of Hope Medical Center - Duarte
  • South Pasadena Cancer Center - South Pasadena

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2013-09-30
Est. Completion 2026-11-30

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT01992432

The ClinicalTrials.gov registry entry for NCT01992432 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01992432 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01992432 about?

NCT01992432 is a clinical study titled "Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)". This study will use advanced MRI techniques to characterize the changes that occur to the structure and functionality of the brain in older breast cancer patients receiving adjuvant chemotherapy, and determine the relationship between the brain changes and severity of chemotherapy toxicity. Our resu...

What is the current status of trial NCT01992432?

This trial is currently active not recruiting. The enrollment target is 49 participants. The study started on 2013-09-30. Estimated completion is 2026-11-30.

What conditions does trial NCT01992432 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT01992432?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01992432 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.